Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

US health and human services secretary Robert F Kennedy Jr announced Tuesday the US federal government is canceling around ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

Health Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

The Pfizer vaccine is the first to receive FDA approval, while the Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. For children ages 12 to 15, Pfizer's ...

Pfizer(PFE -0.46%) and Moderna (MRNA -1.74%) have been in agreement on a lot since the beginning of the pandemic. They both recognized the importance of eventually launching combined vaccines ...

Pfizer and Moderna have experienced tremendous success with their COVID-19 vaccines recently, which have swelled their coffers. See which stock is a better buy.

Pfizer is a big pharmaceutical player with many blockbusters on the market. Moderna is a dynamic young biotech with a full pipeline of candidates, built on its game-changing messenger RNA technology.

What's happening Updated COVID boosters from Pfizer and Moderna are available to everyone 6 months and older. Some adults can get Novavax for a booster instead. Why it matters As the virus mutates ...